✦ LIBER ✦

Phase II trial of D-Trp-6-LH-RH (long releasing formulation) in advanced prostatic cancer

✍ Scribed by G. Mathé; R. Keiling; J. Gastlaburu; M.L. VoVan; G. Prévot; J.M. Vannetzel; R. Despax; C. Jasmin; F. Lévi; M. Musset; P. Ribaud; J.L. Misset

Book ID: 116006655
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 112 KB
Volume: 28
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(87)91324-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase ii trial of D-Trp-6-LH-RH in advan

Phase ii trial of D-Trp-6-LH-RH in advanced breast cancer

✍ G. Mathe; R. Helling; J. Gastlaburu; M.L.. VoVan; G. Prévot; P. Ribaud; C. Jasmi 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 155 KB

An oriented phase-II trial ofd-Trp6-LH-R

An oriented phase-II trial ofd-Trp6-LH-RH in patients with prostatic carcinoma

✍ G. Mathé; M. L. Vovan; J. Duchier; J. L. Misset; P. Morin; R. Keiling; L. Schwar 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 246 KB

Reversible inhibition of testicular andr

Reversible inhibition of testicular androgen secretion by 3-, 5- and 6-month controlled-release microsphere formulations of the LH-RH agonist [d-Trp6, des-Gly-NH210] LH-RH ethylamide in the dog

✍ D. Lacoste; F. Labrie; D. Dubé; A. Bélanger; T. Tice; R.M. Gilley; K.L. Pledger 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 889 KB

Phase II trial of intravenous hexamethyl

Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancer

✍ Mark D. Hauge; Harry J. Long; Lynn C. Hartmann; John H. Edmonson; Maurice J. Web 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 192 KB

Long-term survival in phase II trials of

Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer. Stadler WM, Hayden A, von der Maase H, Roychowdhury D, Dogliotti L, Seymour L, Kaufmann D, Moore M, Department of Medicine, University of Chicago, Chicago, IL: Urol Oncol 2002;7:153–157

✍ Donald L Trump 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 15 KB

Phase III trial of long-term adjuvant an

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02: Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU, Radiation Therapy Oncology Group, Fox Chase Cancer Center and Radiation Therapy Oncology Group, Phialdelphia, PA

✍ Michael Zelefsky 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 21 KB